Controversies in the Management of Posterior Uveal Melanoma

  • Jerry A. Shields
  • Carol L. Shields
  • Luther W. Brady
  • J. Carlos Hernandez
Part of the Medical Radiology book series (MEDRAD)

Abstract

The management of malignant melanoma of the posterior uvea (ciliary body and choroid) is still controversial (Shields 1983; Shields and Shields 1992; Shields et al., to be published). This controversy has evolved because the peculiar and often unpredictable behavior of this tumor is poorly understood. This chapter discusses some of the controversial issues, with emphasis on the debate over the role of enucleation as primary treatment, the subject of metastasis following enucleation, the possibility that enucleation may promote metastasis, and the concept of subclinical metastasis. It will lay the groundwork for the more specific methods of treatment to be discussed in subsequent chapters.

Keywords

Argon Cobalt Radionuclide Stein Xenon 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Felberg NT, Shields JA, Maguire J et al. (1983) Gammaglutamyl transpeptidase in the prognosis of patients with uveal malignant melanoma. Am J Ophthalmol 95:467–473PubMedGoogle Scholar
  2. Manschot WA, van Peperzeel HA (1980) Choroidal melanoma: enucleation or observation? A new approach. Arch Ophthalmol 98:71PubMedCrossRefGoogle Scholar
  3. McLean IW, Zimmerman LE, Evans RM (1978) Reappraisal of Callender’s spindle A type of malignant melanoma of the choroid and ciliary body. Am J Ophthalmol 86:557–564PubMedGoogle Scholar
  4. Seigel D, Myers M, Ferris F III, Steinhorn SC (1979) Survival rates after enucleation of eyes with malignant melanoma. Am J Ophthalmol 87:761–765PubMedGoogle Scholar
  5. Shields JA (1983) Diagnosis and management of intraocular tumors, Chap. 10. CV Mosby, St. LouisGoogle Scholar
  6. Shields JA (1988) Counseling the patient with a posterior uveal melanoma. Am J Ophthalmol 106:88–91PubMedCrossRefGoogle Scholar
  7. Shields JA, Shields CL (1988) Surgical approach to lamellar sclerouvectomy for posterior uveal melanomas. The 1986 Schoenberg Lecture. Ophthalmic Surg 19:774–780PubMedGoogle Scholar
  8. Shields JA, Shields CL (1990) Current alternatives in the management of posterior uveal melanomas. Trans Pa Acad Ophthalmol Otolaryngol 42:938–944PubMedGoogle Scholar
  9. Shields JA, Shields CL (1992) Intraocular tumors. A text and atlas. WB Saunders, PhiladelphiaGoogle Scholar
  10. Shields JA, Shields CL (1990) Current alternatives in the management of posterior uveal melanomas. Trans Pa Acad Ophthalmol Otolaryngol 42:938–944PubMedGoogle Scholar
  11. Shields JA, Zimmerman LE (1973) Lesions simulating malignant melanomas of the posterior uvea. Arch Ophthalmol 89:466–471PubMedCrossRefGoogle Scholar
  12. Shields JA, Augsburger JJ, Brady LW, Day JL (1982) Cobalt plaque therapy for posterior uveal melanomas. Ophthalmology 89:1201–1207PubMedGoogle Scholar
  13. Shields JA, Augsburger JJ, Dougherty MJ (1984) Orbital recurrence of choroidal melanoma 20 years after enucleation. Am J Ophthalmol 97:767–770PubMedGoogle Scholar
  14. Shields JA, Augsburger JJ, Donoso LA, Bernardino B, Portenar M (1985) Hepatic metastasis and orbital recurrence of uveal melanoma after 42 years. Am J Ophthalmol 100:666–668PubMedGoogle Scholar
  15. Shields JA, Glazer LC, Mieler WF, Shields CL, Gottlieb MS (1990) Comparison of xenon arc and argon laser photocoagulation in the treatment of choroidal melanomas. Am J Ophthalmol 109:647–655PubMedGoogle Scholar
  16. Shields JA, Shields CL, Donoso LA (1991) Review: current management of posterior uveal melanoma. Surv Ophthalmol 36:161–195PubMedCrossRefGoogle Scholar
  17. Zimmerman LE, McLean IW (1979a) An evaluation of enucleation in the management of uveal melanomas. Am J Ophthalmol 87:741–760PubMedGoogle Scholar
  18. Zimmerman LE, McLean IW (1979b) Metastatic disease from untreated uveal melanomas. Am J Ophthalmol 88:524–534PubMedGoogle Scholar
  19. Zimmerman LE, McLean IW (1984) Do growth and onset of symptoms of uveal melanomas indicate subclinical metastasis? Ophthalmology 91:685–691PubMedGoogle Scholar
  20. Zimmerman LE, McLean IW, Foster WD (1978) Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells? Br J Ophthalmol 62:420–425PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • Jerry A. Shields
    • 1
  • Carol L. Shields
    • 2
  • Luther W. Brady
    • 3
  • J. Carlos Hernandez
    • 3
  1. 1.Oncology Service, Willis Eye HospitalThomas Jefferson UniversityPhiladelphiaUSA
  2. 2.Willis Eye HospitalThomas Jefferson UniversityPhiladelphiaUSA
  3. 3.Department of Radiation Oncology and Nuclear MedicineHahnemann UniversityPhiladelphiaUSA

Personalised recommendations